Delivery Order SPE2DB20D3104-SPE2DB25FV9C4
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,410.00 to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This is a firm fixed-price delivery order with an ultimate completion date of August 19, 2025, and represents a non-competitive set-aside. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and healthcare...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,389.38 on August 13, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This is a firm fixed price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 14, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under the...
- The Defense Logistics Agency awarded a $3,013.61 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Mucinex D ER 600-60 mg tablets (18-count units) on July 24, 2025, with completion targeted for July 25, 2025. This non-set-aside delivery order represents a routine pharmaceutical supply transaction supporting federal medical procurement needs. The award was issued to AmerisourceBergen's Corporate Office division, with performance to occur at the company's headquarters in...
- The U.S. Defense Department's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Mucinex D ER 600-60 mg tablets in quantities of 18 units. This firm fixed-price delivery order, valued at $10,118.97, is scheduled for completion by September 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation,...
- The Defense Logistics Agency awarded a delivery order valued at $1,227.54 to AmerisourceBergen Drug Corp on August 4, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count package). This firm fixed-price, competitively awarded contract with an ultimate completion date of August 5, 2025, represents a child order under AmerisourceBergen's larger indefinite delivery contract with DLA. The product will be performed from the contractor's location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded AmerisourceBergen Drug Corp a delivery order valued at $2,129.30 for Mucinex D ER 600-60 mg tablets (18-count) on August 21, 2025, with an ultimate completion date of August 22, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed price terms and represents a child delivery order under AmerisourceBergen's existing DLA Troop Support Medical Indefinite Delivery Contract (IDC SPE2DX), valued at $999,999,999.00 and extending...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count units) with a ceiling value of $3,206.04. This competitively awarded, firm fixed-price delivery order is scheduled for completion by August 29, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract contains no set-aside designation, reflecting the company's competitive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Mucinex D ER 600-60 mg tablets (18-count packages) with a ceiling value of $1,509.56. This competitive, firm fixed-price delivery order was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. The pharmaceutical product will be performed and delivered from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a $1,472.20 delivery order to AmerisourceBergen Drug Corp on July 21, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count packages). This firm fixed-price, non-set-aside contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. Performance is scheduled for completion by July 22, 2025, with fulfillment based at...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 25, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $2,218.14. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for ultimate completion by July 28, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. This delivery order is...
- SPE2DB20D3104Indefinite Delivery Contract
- SPE2DB20D3104-SPE2DB25FV9C4Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Mucinex D ER 600-60 mg tablets (18-count) with a ceiling value of $1,331.80. This is a firm fixed-price delivery order issued under AmerisourceBergen's Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. The contract carries no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of July 25, 2025. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal military and veteran healthcare systems. As a prime contractor under the DLA Troop Support Medical program, the company supplies a comprehensive range of pharmaceutical products and medical supplies to support military healthcare operations globally. This delivery order represents a routine procurement of an over-the-counter pharmaceutical product through the broader pharmaceutical prime vendor contract vehicle that DLA has established to streamline medical supply chain operations across the Department of Defense and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.3k | 7/24/25 |